MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Psoriasis: Treatment and Pathogenesis
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

2,393 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
2,393 works in the cohort · of 4,299,418page 36 of 48

Labels cover 8 of 2,393 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 2,393 of 2,393 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

fundno affunlabeled
Efficacy of a Day-Care Program in the Treatment of Psoriasis
Junling Zhang, David N. Adam, Elaine Stebbing, Judith Gerbrandt, Harvey Lui, Jerry Shapiro +1 more
2008· article· en· Journal of Cutaneous Medicine and Surgery· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
1
citations
venueno affno abstractunlabeled
10.1016/s1541-9800(05)70521-4
2000· article· en· Time to knit· Immunology and Microbiology
machine prediction:candidate · insufficient_payloadconsensus · insufficient_payload
0
citations
venueno affno abstractunlabeled
10.1016/s1544-8800(12)70328-7
2000· article· en· Time to knit· Immunology and Microbiology
machine prediction:candidate · insufficient_payloadconsensus · insufficient_payload
0
citations
affunlabeled
MOBY Phantom Mouse Maps
2022· other· en· Zenodo (CERN European Organization for Nuclear Research)· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Economic Group
2004· article· en· Immunology and Microbiology
machine prediction:candidate · insufficient_payloadconsensus · insufficient_payload
0
citations
affno abstractunlabeled
Icotrokinra, peptide oral ciblé bloquant sélectivement le récepteur de l’interleukine-23, pour le traitement du psoriasis en plaque modéré à sévère: résultats jusqu’à la semaine 24 de l’essai de phase 3 ICONIC-LEAD
Robert Bissonnette, T. Passeron, Jennifer Soung, Adelaide A. Hebert, Andrew Pink, A. Pinter +6 more
2025· article· fr· Annales de Dermatologie et de Vénéréologie - FMC· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
0
citations
affno abstractunlabeled
Réponse au bimékizumab jusqu’à 3 ans de traitement chez des patients atteints de psoriasis en plaques modéré à sévère ayant répondu après 16 semaines : résultats de l’extension en ouvert de BE RADIANT
Richard G. Langley, Pablo Fernández‐Peñas, James G. Krueger, Ulrich Mrowietz, C. Paul, M. Wang +6 more
2023· article· fr· Annales de Dermatologie et de Vénéréologie - FMC· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
0
citations
affno abstractunlabeled
Résultats groupés des essais de phase 3 DERMIS-1 et DERMIS-2 relatifs à l’efficacité et à l’innocuité de l’application uniquotidienne de la crème de roflumilast à 0,3 % pour le traitement du psoriasis en plaques chronique
Mark Lebwohl, Melinda Gooderham, Scott Guenthner, H.H. Chih-Ho, L. Kircik, Angela Moore +5 more
2023· article· fr· Annales de Dermatologie et de Vénéréologie - FMC· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
0
citations
affno abstractunlabeled
Persistance de l’amélioration clinique du psoriasis génital après un an de traitement par ixékizumab : résultats d’une étude clinique de phase 3 randomisée contrôlée versus placebo chez des patients atteints de psoriasis génital modéré à sévère (IXORA-Q)
Lyn Guenther, A Potts, Jamie Weisman, Yves Poulin, Lynda Spelman, Russel Burge +5 more
2019· article· fr· Annales de Dermatologie et de Vénéréologie· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
0
citations
venueno affno abstractunlabeled
10.1016/s1541-9800(07)70433-7
2000· article· en· Time to knit· Immunology and Microbiology
machine prediction:candidate · insufficient_payloadconsensus · insufficient_payload
0
citations
affno abstractunlabeled
GLP-1R Agonists in Psoriasis Patients
Rochelle F. McAdam, Ronald Vender
2023· letter· en· Journal of Cutaneous Medicine and Surgery· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
0
citations
affno abstractunlabeled
Étude observationnelle prospective de 24 mois de la persistance du traitement chez des patients atteints de rhumatisme psoriasique (PRO-SPIRIT) – conception de l’étude et caractéristiques des patients à l’inclusion (échantillon complet)
Jérôme Morel, Ennio Lubrano, William Tillett, Rieke Alten, Lars Erik Kristensen, Vinod Chandran +5 more
2023· article· fr· Revue du Rhumatisme· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
0
citations
affno abstractunlabeled
97-P
Abdelhamid Liacini, Duaa Ibrahim, Faridi Rehan, Faisal Khan, Aylin Sar, Serdar Yılmaz +1 more
2012· article· en· Human Immunology· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
0
citations

How this was built: Screen · Findings · About